FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Human Disease Model Report: congenital heart defect (postulated), UBB-related
Open Close
General Information
Name
congenital heart defect (postulated), UBB-related
FlyBase ID
FBhh0001347
OMIM
Overview

Congenital heart defect (CHD), also described as congenital heart disease, is the most common type of birth defect; it is thought to have a significant genetic component. Candidate genes identified in a large-scale exome sequencing analysis have been assessed in a fly system using cardiac-targeted gene silencing of orthologous fly genes. Experiments using the Drosophila ortholog Ubi-p63E support UBB as a candidate gene in the development of CHD.

In a large-scale exome sequencing analysis in Nigeria, a frameshift insertion in the UBB gene was found in a child diagnosed with tetralogy of Fallot.

UBB encodes ubiquitin, a small and extremely conserved protein that has a major role in targeting cellular proteins for degradation. Ubiquitin is synthesized as a precursor protein consisting of polyubiquitin chains; although the human UBB gene and fly Ubi-p63E gene encode a differing number of ubiquitin entities, the processed ubiquitin proteins are 100% identical. There are multiple genes that encode ubiquitin in both species. The human Hsap\UBB gene has been introduced into flies, but has not been characterized in the context of this disease model.

Animals homozygous for amorphic alleles of Dmel\Ubi-p63E are viable, but male sterile. Targeted knockdown of Ubi-p63E restricted to the developing heart, effected by RNAi, results in 100% lethality prior to the adult stage. Physical and genetic interactions of Dmel\Ubi-p63E have been described; see below and in the Ubi-p63E gene report.

[updated May 2021 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: congenital heart defect
Symptoms and phenotype

A congenital heart defect is a problem with the structure of the heart; it is the most common type of birth defect. The defects can involve the walls of the heart, the valves of the heart, and the arteries and veins near the heart. They can disrupt the normal flow of blood through the heart: the blood flow can slow down, go in the wrong direction or to the wrong place, or be blocked completely (https://medlineplus.gov/congenitalheartdefects.html).

Defects range from simple, which might cause no problems, to complex, which can cause life-threatening complications. The most serious defects are categorized as critical congenital heart defects (CCHD). CCHD is life threatening and requires intervention in infancy; approximately 18 out of 10,000 babies are born with CCHD (https://www.aap.org/en-us/advocacy-and-policy/aap-health-initiatives/PEHDIC/Pages/Newborn-Screening-for-CCHD.aspx).

Genetic causes of congenital heart disease also account for many of the comorbidities seen with increased frequency in congenital heart disease patients, including neurodevelopmental disability, pulmonary disease, arrhythmia, renal disease, heart failure and an increased incidence of malignancy. (Simmons and Brueckner, 2017; pubmed:28872494).

A number of well studied syndromes, including DiGeorge syndrome, Williams-Beuren syndrome, Alagille syndrome, Noonan syndrome, and Holt-Oram syndrome, include congenital heart defect (Pierpont et al., 2007; pubmed:17519398).

Congenital heart defects (CHTD) are among the most common congenital defects, occurring with an incidence of 8/1,000 live births. The etiology of CHTD is complex, with contributions from environmental exposure, chromosomal abnormalities, and gene defects. [from MIM:306955; 2018.11.13]

Specific Disease Summary: congenital heart defect (postulated), UBB-related
OMIM report
Human gene(s) implicated
Symptoms and phenotype
Genetics
Cellular phenotype and pathology
Molecular information

UBB encodes ubiquitin, a highly conserved protein that has a major role in targeting cellular proteins for degradation by the 26S proteosome. It is also involved in the maintenance of chromatin structure, the regulation of gene expression, and the stress response. Ubiquitin is synthesized as a precursor protein consisting of either polyubiquitin chains or a single ubiquitin moiety fused to an unrelated protein. [Gene Cards, UBB; 2021.05.15]

The human UBB gene consists of 3 ubiquitin entities; the fly Ubi-p63E gene consists of 9; the resulting fly and human ubiquitin processed proteins share 100% identity.

External links
Disease synonyms
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
Symbol / Name
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to many: multiple related genes in both species; differ in number of polyubiquitin repeats.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Gene Snapshot
    Ubiquitin-63E (Ubi-p63E) encodes a polyubiquitin precursor: once processed by deubiquitinating enzymes, it produces ten ubiquitin molecules, which are predominantly conjugated to target proteins. Ubiquitin conjugation is involved in a wide range of biological processes, such as protein degradation, endocytosis of plasma membrane proteins, protein trafficking, DNA-damage response and inflammation and immune system response. [Date last reviewed: 2018-09-06]
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    Extremely highly conserved ortholog of human UBB and UBC (differ in number of polyubiquitin repeats); multiple other related genes in both species.

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (23 groups)
      protein-protein
      Interacting group
      Assay
      References
      ion exchange chromatography, peptide massfingerprinting
      anti tag coimmunoprecipitation, western blot, anti bait coimmunoprecipitation, Identification by mass spectrometry
      split luciferase complementation, luminiscence technology
      deubiquitinase assay, anti tag western blot, molecular weight estimation by staining
      anti tag coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, anti tag western blot, western blot
      anti tag coimmunoprecipitation, peptide massfingerprinting
      split luciferase complementation, luminiscence technology
      pull down, western blot
      pull down, western blot, anti tag coimmunoprecipitation, anti tag western blot
      pull down, western blot
      split luciferase complementation, luminiscence technology
      split luciferase complementation, luminiscence technology
      enzymatic study, western blot, pull down
      pull down, western blot
      anti bait coimmunoprecipitation, western blot
      anti tag coimmunoprecipitation, western blot, pull down, peptide massfingerprinting
      anti tag coimmunoprecipitation, anti tag western blot
      anti tag coimmunoprecipitation, anti tag western blot
      anti bait coimmunoprecipitation, anti tag western blot, pull down
      anti tag coimmunoprecipitation, covalent binding, anti tag western blot
      split luciferase complementation, luminiscence technology
      split luciferase complementation, luminiscence technology
      Alleles Reported to Model Human Disease (Disease Ontology) (1 alleles)
      Models Based on Experimental Evidence ( 0 )
      Allele
      Disease
      Evidence
      References
      Modifiers Based on Experimental Evidence ( 1 )
      Allele
      Disease
      Interaction
      References
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      amorphic allele - genetic evidence
      ethyl methanesulfonate
      amorphic allele - genetic evidence
      ethyl methanesulfonate
      amorphic allele - genetic evidence
      ethyl methanesulfonate
      amorphic allele - genetic evidence
      ethyl methanesulfonate
      amorphic allele - molecular evidence
      Delta2-3 transposase
      amorphic allele - molecular evidence
      Delta2-3 transposase
      References (4)